“Among U.S. adults, 80% say insurers should cover weight loss drugs for adults diagnosed as overweight or obese.”
The GLP-1 Dilemma Persists Into 2025
“Half of respondents also said insurance should cover the drugs even if it would increase premium costs…. According to [one] survey of more than 2,000 employers in 2024, 44% with 500 or more employees offer GLP-1 coverage for obesity. Among employers with 20,000 or more employees, 64% offer coverage.”
Becker’s Hospital Review
